Alpha Wealth Funds LLC Takes Position in Grail, Inc. (NASDAQ:GRAL)

Alpha Wealth Funds LLC bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 143,547 shares of the company's stock, valued at approximately $2,562,000. Grail makes up 2.5% of Alpha Wealth Funds LLC's portfolio, making the stock its 5th largest position. Alpha Wealth Funds LLC owned approximately 0.43% of Grail as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Ameriflex Group Inc. bought a new stake in Grail during the 4th quarter valued at $95,000. PVG Asset Management Corp bought a new stake in Grail during the 4th quarter valued at $398,000. Public Employees Retirement System of Ohio bought a new stake in shares of Grail in the 4th quarter worth $334,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in shares of Grail in the 4th quarter worth $1,201,000. Finally, Westwood Holdings Group Inc. bought a new stake in shares of Grail in the 4th quarter worth $1,389,000.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Morgan Stanley boosted their price objective on Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research note on Tuesday, March 18th. Canaccord Genuity Group lifted their price target on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a report on Wednesday, May 14th.

Insider Buying and Selling

In other Grail news, CFO Aaron Freidin sold 1,816 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares of the company's stock, valued at approximately $10,457,304. The trade was a 0.54% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the business's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now directly owns 559,673 shares of the company's stock, valued at $17,461,797.60. This represents a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 194,948 shares of company stock valued at $6,583,130 over the last ninety days. 1.85% of the stock is owned by company insiders.

Grail Stock Down 8.3%

GRAL stock traded down $3.40 during midday trading on Friday, hitting $37.70. 1,588,983 shares of the company traded hands, compared to its average volume of 1,256,076. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The business has a 50 day simple moving average of $32.06 and a 200-day simple moving average of $28.49. The stock has a market capitalization of $1.36 billion and a price-to-earnings ratio of -0.62.

Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analyst estimates of $35.80 million. Equities research analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.